Literature DB >> 2556840

Size and stability of the Epstein-Barr virus major internal repeat (IR-1) in Burkitt's lymphoma and lymphoblastoid cell lines.

G J Allan1, D T Rowe.   

Abstract

We have used field inversion gel electrophoresis to survey EBV strains for the size of the major internal repeat, IR-1, and estimate the number of 3.1-kb repeat units present. The B95-8 strain of EBV was estimated to contain 8.6 repeats. The repeat number varies considerably among naturally occurring isolates around a mean of six repeats. Some cell lines harbored multiple viral genomes with differing numbers of repeats and our results suggest that the repeat number in IR-1 is more likely to change during lytic replication than during latency. The Jijoye strain had 6.6 repeats and the Jijoye deletion mutant clone P3HR-1 retained 5.9 repeats setting the size of the P3HR-1 deletion at 6.8 kb. Thus, the nonimmortalizing mutant has retained all of the W1 and W2 exons of the immortalizing parent and has lost only the 3' unique exons of EBNA4 and all of EBNA2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556840     DOI: 10.1016/0042-6822(89)90561-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.

Authors:  Isabel A Hutchings; Rosemary J Tierney; Gemma L Kelly; Julianna Stylianou; Alan B Rickinson; Andrew I Bell
Journal:  J Virol       Date:  2006-08-18       Impact factor: 5.103

2.  Stimulus duration and response time independently influence the kinetics of lytic cycle reactivation of Epstein-Barr virus.

Authors:  Jill Countryman; Lyndle Gradoville; Sumita Bhaduri-McIntosh; Jianjiang Ye; Lee Heston; Sarah Himmelfarb; Duane Shedd; George Miller
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

3.  Autoantigenic proteins that bind recombinogenic sequences in Epstein-Barr virus and cellular DNA.

Authors:  R Sun; T A Spain; S F Lin; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

4.  Optimal lengths for DNAs encapsidated by Epstein-Barr virus.

Authors:  T A Bloss; B Sugden
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Detection of EBV genomes in plasmablasts/plasma cells and non-B cells in the blood of most patients with EBV lymphoproliferative disorders by using Immuno-FISH.

Authors:  Sara Calattini; Irini Sereti; Philip Scheinberg; Hiroshi Kimura; Richard W Childs; Jeffrey I Cohen
Journal:  Blood       Date:  2010-08-10       Impact factor: 22.113

6.  Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.

Authors:  Robert E White; Ian J Groves; Ernest Turro; Jade Yee; Elisabeth Kremmer; Martin J Allday
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

7.  Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program.

Authors:  Rosemary Tierney; Jasdeep Nagra; Isabel Hutchings; Claire Shannon-Lowe; Markus Altmann; Wolfgang Hammerschmidt; Alan Rickinson; Andrew Bell
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

8.  Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers.

Authors:  Yo Hoshino; Harutaka Katano; Ping Zou; Patricia Hohman; Adriana Marques; Stephen K Tyring; Dean Follmann; Jeffrey I Cohen
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

9.  Commutability of the Epstein-Barr virus WHO international standard across two quantitative PCR methods.

Authors:  Janaki Abeynayake; Ryan Johnson; Paolo Libiran; Malaya K Sahoo; Hongbin Cao; Raffick Bowen; K C Allen Chan; Quynh-Thu Le; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2014-07-30       Impact factor: 5.948

10.  Novel downstream elements upregulate transcription initiated from an Epstein-Barr virus latent promoter.

Authors:  D Walls; M Perricaudet
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.